Xprecia™ System PT/INR Strips - Xprecia™ System PT/INR Strips, is intended for - Siemens Healthcare Diagnostics Inc.

Duns Number:064608573

Device Description: Xprecia™ System PT/INR Strips, is intended for use by professional healthcare providers to Xprecia™ System PT/INR Strips, is intended for use by professional healthcare providers to provide an INR (International NormalizedRatio) based on a prothrombin time (PT) response for the monitoring of oral anticoagulation therapy with warfarin

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

11065645

Brand Name

Xprecia™ System PT/INR Strips

Version/Model Number

11065645

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

K151964,K151964

Product Code Details

Product Code

GJS

Product Code Name

TEST, TIME, PROTHROMBIN

Device Record Status

Public Device Record Key

031e0b1e-796a-4a03-9f4a-0e1441489ece

Public Version Date

November 19, 2021

Public Version Number

5

DI Record Publish Date

March 01, 2017

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"SIEMENS HEALTHCARE DIAGNOSTICS INC." Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 363
2 A medical device with a moderate to high risk that requires special controls. 829
3 A medical device with high risk that requires premarket approval 57
U Unclassified 7